EP4028001
RIFABUTIN MEÐFERÐARAÐFERÐIR, NOTKUN OG SAMSETNINGAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.8.2020EP published:
10.4.2024EP application number:
20768692.4
EP translation filed:
24.6.2024Grant published:
15.8.2024EPO information:
European Patent Register
Max expiry date:
2.8.2040Expiry date:
2.8.2026Next due date:
31.8.2026
Title in English:
RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONSLanguage of the patent:
English
Timeline
Today
3.8.2020EP application
10.4.2024EP Publication
24.6.2024Translation submitted
15.8.2024Registration published
2.8.2026Expires
Owner
Name:
Bioversys AGAddress:
Technologiepark Basel Hochbergerstrasse 60c, 4057 Basel, CH
Inventor
Name:
DALE, Glenn, E.Address:
4059 Basel, CH
Name:
LOCIURO, SergioAddress:
4058 Basel, CH
Name:
KEMMER, ChristianAddress:
4125 Riehen, CH
Name:
TREBOSC, VincentAddress:
68170 Rixheim, FR
Name:
GITZINGER, MarcAddress:
4057 Basel, CH
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
201962899257 PDate:
12.9.2019Country:
US
Number:
201962902019 PDate:
18.9.2019Country:
US
Number:
201962941160 PDate:
27.11.2019Country:
US
Number:
202062977659 PDate:
17.2.2020Country:
US
Classification
Categories:
A61K 31/546, A61K 31/438, A61K 9/00, A61P 31/04, A61K 38/12
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.8.2024
Expires: 2.8.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 18.7.2025
Expires: 2.8.2026
Payer: Árnason Faktor ehf.